ZEROFOS 667MG TABLET

The active component in Zerofos 667 mg tablet  is Calcium acetate. Hyperphosphatemia, or high blood phosphates, is treated with this medication. It is primarily prescribed to patients who have chronic kidney disease and end-stage renal disease (ESRD). It can help maintain bone health and reduce the risk of fractures and other bone-related issues. The Zerofos 667mg tablet may help reduce cardiovascular issues such as heart disease or calcification in blood vessels. It can be used in conjunction with dietary changes to improve the control of phosphate levels. High phosphate levels are associated with symptoms such as itching and skin irritation, common among people with kidney disease. It may help to relieve these symptoms by lowering phosphate levels.
You must avoid using this medication if you have an allergy or hypersensitivity to Zerofos 667 mg tablet or its ingredients. Patients should not take this medication with severe renal impairment or impaired calcium metabolism. Individuals with kidney stones, kidney disease or those who take calcium or magnesium-containing medications should exercise caution. It is generally not recommended for children because there is insufficient data on pediatric populations. Older people should only use this medication cautiously, as so many health issues can arise in old age. These include impaired kidney function and cardiovascular problems, among others. Always consult with a doctor before taking this medication as you age.